Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
The Zacks Analyst Blog Highlights: Alibaba, Toyota Motor, Bristol-Myers Squibb, S&P Global and Uber Technologies...…
The acquisition of Celgene is working wonders so far....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…
Merck (MRK), Bristol Myers (BMY), Sanofi (SNY), Glaxo (GSK) and Novo Nordisk (NVO) announce Q4 results....…
Bristol-Myers (BMY) beats both earnings and sales estimates in the fourth quarter, primarily on robust sales of Eliquis and acquisition…
BMY earnings call for the period ending December 31, 2019....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
The pharmaceutical giants guidance also looks good....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Bristol-Myers Squibb Co
said on Thursday its operating profit rose by around a third
from a year ago because fourth-quarter results included…
In a word: Celgene....…
NEW YORK (dpa-AFX) - Nach der Übernahme des Biopharmaspezialisten Celgene hat der Pharmakonzern Bristol-Myers Squibb im vierten Quartal einen Verlust…
NEW YORK (dpa-AFX) - Nach der Übernahme des Biopharmaspezialisten Celgene hat der Pharmakonzern Bristol-Myers Squibb …
Bristol-Myers: Celgene-Übernahme zahlt sich aus...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Shares of Bristol-Myers Squibb were up 2% in premarket trading on Thursday after the company beat earnings estimates for…
Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…
Bristol-Myers Squibb Co
said on Thursday its operating profit rose by around a third
from a year ago because fourth-quarter results included…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Bristol-Myers Squibbs top 3 selling drugs (excluding that of Celgene) are Eliquis, Opdivo, and Orencia. These three drugs combined, likely…
Yale University has developed the intellectual property behind Anteros and was first in-licenced by BMS and later authorised to Anteros.…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Investors will focus on the performance of Opdivo, Revlimid and Eliquis along with the regular top and bottom-line numbers when…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Bristol-Myers (BMY) has withdrawn its application in the EU for the Opdivo and Yervoy combo for the treatment of advanced…
Investors will focus on regular top and bottom-line numbers along with key pipeline updates when Bristol-Myers (BMY) reports fourth-quarter results....…
Biotech stocks see-sawed through the week ended Jan. 31 and ended the month lower overall. Big pharma earnings of the…
Regulators said its impossible to evaluate the drug with so many clinical trial alterations....…
Drugmaker Bristol-Myers Squibb
Co said on Friday it was pulling the application to have
its immunotherapies Opdivo and Yervoy approved in Europe…
Drugmaker Bristol-Myers Squibb
Co said on Friday it was pulling the application to have
its immunotherapies Opdivo and Yervoy approved in Europe…
Drugmaker Bristol-Myers Squibb
Co said on Friday it was pulling the application to have
its immunotherapies Opdivo and Yervoy approved in Europe…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Drugmaker Bristol Myers Inc
said on Friday it was pulling the application to have
its immunotherapies Opdivo and Yervoy approved in Europe…
Drugmaker Bristol Myers Inc
said on Friday it was pulling the application to have
its immunotherapies Opdivo and Yervoy approved in Europe…
John Donahoe, ServiceNow CEO, discusses the company's quarterly earnings, first-quarter guidance, taking on new customers such as Bristol-Myers Squibb and…
A search for healthy companies bucking the trend toward high P/Es turned up only a handful of names. How Discovery,…
Bristol-Myers Squibb (BMY) closed the most recent trading day at $64.81, moving +1.74% from the previous trading session....…
Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
The newly combined Bristol-Myers Squibb and Celgene is shaping up to be a formidable company in the pharmaceutical industry.
Its now…
A jury that told Gilead Sciences to pay $752 million worth of patent infringement damages didnt go as far as…
Bristol-Myers (BMY) could produce exceptional returns because of its solid growth attributes....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Bristol-Myers Squibb and Merck primarily serve the pharmaceuticals products markets. The companies discover, develop, and sell pharmaceutical products globally. Their…
UBS, Delta, American Airlines, Pfizer and Bristol-Myers Squibb are among the companies with shares expected to trade actively Tuesday....…
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to…
EVOTEC UND BRISTOL-MYERS SQUIBB ERWEITEREN IPSC-ALLIANZ...…
Der Wirkstoffforscher Evotec kann sich im Zuge einer erweiterten Zusammenarbeit mit dem Pharmakonzern Bristol-Myers Squibb (BMS) über eine Millionenzahlung freuen.…